US stock · Healthcare sector · Biotechnology
Company Logo

ImmunoGen, Inc.

IMGNNASDAQ

3.68

USD
+0.21
(+6.05%)
Market Closed
-7.20P/E
-5Forward P/E
-0.28P/E to S&P500
811.572MMarket CAP
- -Div Yield
Google Trends
Recent Reddit Comments

SAVA, FATE, CNSP, GLMD, IMGN

1
Reply
Share
Report
Save
Follow

IMGN very good today

1
Reply
Share
Report
Save
Follow

don't fall in love with a stock. I'm still in it. fell in love with IMGN. bought 10k shares. have held it for 30 years

1
Reply
Share
Report
Save
Follow

IMGN 😍💵

0
Reply
Share
Report
Save
Follow

why is imgn flying

0
Reply
Share
Report
Save
Follow

Problem is IMGN and GTBP are doing similar no? They’re also further along and have better teams 🤷‍♂️

1
Reply
Share
Report
Save
Follow

Hi There,

I mostly sell puts that expire in several months. I prefer to run trades all the way to expiration, unless there's some very good reason to exit early. I don't really think about ITM or OTM, but where I think an underlying share price will be by the expiration date, based on close observation over many months. Sometimes that winds up being ITM, and other times, OTM.

You'll never be able to capture all of a move unless you run to expiration (and are right!), so don't worry about a price rising or dropping after you exit.

What problem have you been having? Can you give us specific examples?

To give you an idea, here are some of my plays:

-10 SKLZ 06/18 12.50 P: premium = $1,100

-20 SKLZ 07/19 15.00 P: premium = $2,600

-5 PLTR 08/20 20.00 P: premium = $1,100

-10 PLTR 08/20 22.00 P: premium = $2,600

-5 IMGN 06/18 8.00 C: premium = $119

-10 IMGN 10/15 5.00 P: premium = $1,000

-30 IMGN 10/15 6.00 P: premium = $4,200

-10 NVTA 09/17 35.00 P: premium = $6,100

-50 NNDM 11/19 7.50 P: premium = $8,600

-1 TDOC 10/15 150.00 P: premium = $1,475

-2 PACB 09/17 29.00 P: premium = $1,220

-1 FSLY 01/21 42.00 P: premium = $841

1
Reply
Share
Report
Save
Follow

RKT IMGN ADM ADPT

Good luck! I would advise sticking to sectors you know will be huge: energy, cancer, dna, data, real estate. So much change and work to be done there the winners will be much more valuable in 10 years.

2
Reply
Share
Report
Save
Follow

IMGN lookin' good this morning.

1
Reply
Share
Report
Save
Follow

Sold off my Imgn stock at a $2000 loss and said F it all in on GME. Another 30+ shares at $109 all in with 175 shares

31
Reply
Share
Report
Save
Follow

lets go IMGN

1
Reply
Share
Report
Save
Follow

IMGN$$$$

2
Reply
Share
Report
Save
Follow

PUSH IMGN!!!

2
Reply
Share
Report
Save
Follow

LETS GO my IMGN is doing AMAZING!

1
Reply
Share
Report
Save
Follow

Any thoughts on Imgn stock advice appreciated.

1
Reply
Share
Report
Save
Follow

lets go IMGN!

0
Reply
Share
Report
Save
Follow

LOL my IMGN calls gif

1
Reply
Share
Report
Save
Follow

IMGN go up and up and up!

2
Reply
Share
Report
Save
Follow

lets go IMGN!

1
Reply
Share
Report
Save
Follow

IMGN broke out buy now!

0
Reply
Share
Report
Save
Follow

IMGN is boutta break for the high play

1
Reply
Share
Report
Save
Follow

look at IMGN!

1
Reply
Share
Report
Save
Follow

IMGN!

1
Reply
Share
Report
Save
Follow

IMGN!!!!

-1
Reply
Share
Report
Save
Follow

LETS GO IMGN up so much!

1
Reply
Share
Report
Save
Follow

IMGN going places!

1
Reply
Share
Report
Save
Follow

GSAT, PFE, IMGN gonna explode next week!

0
Reply
Share
Report
Save
Follow

IMGN!

1
Reply
Share
Report
Save
Follow

IMGN hit 9.22 support!

1
Reply
Share
Report
Save
Follow

PFE & IMGN on support levels!

1
Reply
Share
Report
Save
Follow

IMGN hit support. BUY NOW!!!

1
Reply
Share
Report
Save
Follow

lets go IMGN!

1
Reply
Share
Report
Save
Follow

PLTR & IMGN

1
Reply
Share
Report
Save
Follow

IMGN

1
Reply
Share
Report
Save
Follow

IMGN buy now!!!

1
Reply
Share
Report
Save
Follow

IMGN great buy get in before too late!

1
Reply
Share
Report
Save
Follow

buy IMGN before market closes just hit support!!!

1
Reply
Share
Report
Save
Follow

IMGN going to the MOON!

0
Reply
Share
Report
Save
Follow

IMGN is a great buy!

2
Reply
Share
Report
Save
Follow

Why $IMGN is gonna rip all day

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imgn/immunogen/news/need-to-know-analysts-are-much-more-bullish-on-immunogen-inc

https://www.zacks.com/stock/news/1263278/immunogen-imgn-q4-earnings-sales-top-pipeline-on-track

[https://finance.yahoo.com/news/news-flash-analysts-just-made-042548468.html](https://finance.yahoo.com/news/news-flash-analysts-just-made-042548468.html

1
Reply
Share
Report
Save
Follow

$IMGN if you know you know....

1
Reply
Share
Report
Save
Follow

$IMGN GANG STAND UPPP

1
Reply
Share
Report
Save
Follow

IMGN GANG LETS EAT

1
Reply
Share
Report
Save
Follow

$IMGN gang, if you know you know

1
Reply
Share
Report
Save
Follow

IMGN MAKIN US TENDIES TMRW

1
Reply
Share
Report
Save
Follow

WE LIKE $IMGN

1
Reply
Share
Report
Save
Follow

$IMGN going tits up tmrw

-1
Reply
Share
Report
Save
Follow

$IMGN calls gonna print, smashed earnings

3
Reply
Share
Report
Save
Follow

$IMGN RIPPING

1
Reply
Share
Report
Save
Follow

IMGN CALLS BEFORE CLOSE

2
Reply
Share
Report
Save
Follow

IMGN CALLS BEFORE CLOSE

0
Reply
Share
Report
Save
Follow

IMGN calls before close..thank me later

-8
Reply
Share
Report
Save
Follow

IMGN for long investment

1
Reply
Share
Report
Save
Follow

IMGN is fuckin mooning

1
Reply
Share
Report
Save
Follow

LFG BOYS IMGN IS FUCKIN MOONING

3
Reply
Share
Report
Save
Follow

IMGN if u wanna wake up rich tuesday

-2
Reply
Share
Report
Save
Follow

IMGN if you dont wanna be poor anymore

1
Reply
Share
Report
Save
Follow

IMGN make our pee pee hard gang

1
Reply
Share
Report
Save
Follow

IMGN LFG BOYS

1
Reply
Share
Report
Save
Follow

IMGN going to 15 by tuesday

1
Reply
Share
Report
Save
Follow

IMGN LFG BOYS

1
Reply
Share
Report
Save
Follow

IMGN boutta make the next leg up

1
Reply
Share
Report
Save
Follow

Thougths on IMGN?

1
Reply
Share
Report
Save
Follow

IMGN MOONING LFG BOYS GET ON THE WAVE

1
Reply
Share
Report
Save
Follow

IMGN smashing earnings gonna have it running all day

0
Reply
Share
Report
Save
Follow

IMGN to 15$ by next week

1
Reply
Share
Report
Save
Follow

IMGN

1
Reply
Share
Report
Save
Follow

IMGN HOLY FUCK YES.

3
Reply
Share
Report
Save
Follow

IMGN MAKIN US RICH

1
Reply
Share
Report
Save
Follow

IMGN

1
Reply
Share
Report
Save
Follow

IMGN LETS FUCKIN GO

1
Reply
Share
Report
Save
Follow

IMGN TO FUCKIN MARS

1
Reply
Share
Report
Save
Follow

IMGN GANG

1
Reply
Share
Report
Save
Follow

IMGN lets goo

1
Reply
Share
Report
Save
Follow

IMGN so you can wake up happy tuesday

1
Reply
Share
Report
Save
Follow

IMGN LFG

1
Reply
Share
Report
Save
Follow

development stage biotechs never report meaningful income until they establish a revenue stream and your due diligence would have uncovered any potential income prior to the earnings call.

I wouldn't hang all of my money on any single investment and I'm speaking from experience. Holding big on IMGN

1
Reply
Share
Report
Save
Follow

Imgn has my interest as well, heard their might be a spike in June but the only thing scheduled is the BLA, know if that’s enough to move the stock?

1
Reply
Share
Report
Save
Follow

Imgn...someone knows something 🤐

1
Reply
Share
Report
Save
Follow

Imagine being the type of person that says things like "America is a decaying empire".

Imagine.

IMaGiNe.

IMGN.

2
Reply
Share
Report
Save
Follow

Interesting. Where do you see imgn stock being valued in 10 or 20 years?

1
Reply
Share
Report
Save
Follow

I frequently pitch imgn . It is a cancer stock that has been beaten to death over the last 10+ years but are on the verge of a phase3 approval guided by the fda with the structure of their trial for a drug which was not approved the last time it was up for approval. The FDA saw the positivity in the results but were not able to approve without more test results.

End of 2021 should see atleast 1 approval for this company which would easily put it at 20 bucks but a take over could put it in the 10 bagger territory given the number of drugs in the pipeline.

Genentech uses imgn technology in their best cancer drug

1
Reply
Share
Report
Save
Follow

Imgn will be approved for a phase 3 drug at the end of 2021

1
Reply
Share
Report
Save
Follow

GENE 7.5c 1/15and IMGN 10c 1/15 buy that shit 💯 is gonna 🚀🚀🚀🚀 let’s pump these up!!!

1
Reply
Share
Report
Save
Follow

I feel like most of the smaller biotech companies spend much of their long history under $5 pretty much ignored by everyone until one piece of news becomes relevant and those in the know start buying in anticipation of the actual run-up. They usually have a fairly small float (less than 200 million shares) and the stock price can move very quickly once they start making money with a drug.

Prior to earning money, the analysts don't really have a way of putting a value on their technology so investing can be hit or miss.

I've held my IMGN stock for YEARS and it's finally poised for a major move upwards in the next year. (Yes, I've been of this mindset before)

1
Reply
Share
Report
Save
Follow

this second go round could get worse. Small business have already depleted cash reserves. The government doesn't appear to have the will to push through a 2nd stimulus (not sure that would really help very much).

I sold some shares in March and kept some of that cash in case a buying opportunity arises, but I'm long on a lot of reliable steady stocks that hopefully won't experience significant downward pressure. (DEA, WMT, even TSLA have been fairly resilient considering my entry prices)

I'm hoping my IMGN will triple over the next year and keep growing like SGEN which I sold way too soon. It's been a dog for the last 10 years.

1
Reply
Share
Report
Save
Follow

IMGN calls

1
Reply
Share
Report
Save
Follow

Anyone think IMGN calls are a good play? I feel as it is an undervalued stock.

1
Reply
Share
Report
Save
Follow

I wrote a quick program to search for any company that has the key words "convalescent", "plasma", or "convalescent plasma" anywhere in the company description, and I was returned the list of tickers below. Beyond that, I have done no further analysis. Should be a starting point though. Certainly better than trying to sift through the 7000+ companies in the healthcare sector.

"A" "ABC" "ADMA" "AEIS" "AGLE" "AMBD" "APYX" "CANOF" "CERS" "HAE" "IMGN" "KALV" "LCTX" "LOFB" "LRCX" "MKSI" "PHRX" "PIRS" "RYAM" "RZLT" "TTOO"

5
Reply
Share
Report
Save
Follow

Stock Share Gain,%

VUSA 31,7% 1,9%

REGI 12,8% 106,8%

GOOGL 8,6% 16,2%

AMZN 8,5% 72,0%

MSFT 7,8% 14,1%

DDOG 3,6% -3,7%

BRK-B 3,5% -5,6%

NFLX 3,4% 36,4%

AAPL 3,2% 27,7%

DFS 2,7% 43,3%

KO 2,6% 3,3%

XRX 2,5% -33,7%

AMRX 2,3% -6,6%

LPL 2,1% -17,3%

T 1,9% 2,2%

IMGN 1,8% -5,8%

PFE 1,2% -0,8%

TOTAL 100,0% 15,1%

I have start to invest in October 2019. Wanna keep my investments as long term. But if I would see that something is better to sell I will do this.

VUSA, I'm not able to buy VOO, as I'm in Europe, therefore buying VUSA in EUR. Wanna keep it around 33%.

The rest are shares. I was lucky with REGI, gain 106%. Tech companies have the share of 35%. My bad decisions are LPL and XRX as I did it at the beginning. XRX I will keep. But LPL will sell.

The rest at this point of time I'm thinking to keep.

What do you think about my portfolio? Is it too much diverse? Should I sell some companies as there is no sense to keep them? What companies among the list above should I keep as they have very good perspective.

Thanks.

1
Reply
Share
Report
Save
Follow

IMGN

I decided to buy more after watching this investor conference Q&A

https://wsw.com/webcast/canaccord42/imgn/index.aspx

it's a 24 min video.

TLDR: they didn't get p3 approval last time and the FDA told them exactly what they wanted to see inorder to achieve P3 approval. next year should be transformational.

1
Reply
Share
Report
Save
Follow

6000 shares imgn

1
Reply
Share
Report
Save
Follow

The lawsuit, from what I gathered when it originally was brought up, stressed that the CEO said they “found a cure” in 3 hours time, which made investors flock to buy—then when the press conference happened, he recanted his statement and said something to the effect of “we did not find the cure, but we did map the DNA of the virus”.

The issue is partially that they have consistently gotten to phase 2/3—without ever producing the vaccine itself. They already stated that would not be able to mass produce it because they do not have the facilities or production capabilities and were in talks to partner with IMGN, but no other information came from that afterwards. INO has potential, and has consistently increased increased its value—partially because of its releases, and partially because MRNA and NVAX have made progress which they “ride the coattails on”. The pattern of INO has consistently been mid-month press release or development, followed by gap ups that last 2-3 days, then a 3-4 week bleed or yo-yo. It’s been this way since March. It’s up 600-something percent in 5 months time, topping 1,000% at one point.

1
Reply
Share
Report
Save
Follow

I wasn't sure which of the 10-15 to choose. I had VBIV, PFE, and AZN all throughout May and/or June. I gave up too early. I still own a lot of DVAX, so I'm still happy with my research. IMGN and INGN were duds, and I owned some of those too.

2
Reply
Share
Report
Save
Follow

IMGN - Will spike tuesday / Wednesday next week

1
Reply
Share
Report
Save
Follow
Recent Tweets
Is this good for your portfolio? $IMGN RSI Indicator left the oversold zone. #ImmunoGen https://t.co/s0PqmtlwTM https://t.co/o7KLmrXW3f
0
0
0
ImmunoGen $IMGN said Thursday that more than 70% of patients showed tumor reduction in the pivotal study of mirvetuximab soravtansine monotherapy in patients with platinum-resistant ovarian cancer. The study also showed a preliminary median overall survival of 13.8 months.
0
0
0
$IMGN Today we announced additional efficacy and safety analyses evaluating #mirvetuximab soravtansine in #ovariancancer will be presented at #ASCO22. Read the full press release here: https://t.co/JxI1Gqhenp https://t.co/YPJ94BBaDp
0
0
2
$IMGN 🔥 Sentiments: title -0.3818 | summary -0.3818 Aft-Price: 3.73 | Bid: 3.64 | Ask: 3.68 Volume: 4,386,624 https://t.co/flfqUwnYTr
0
0
0
$IMGN ImmunoGen Presents Additional Efficacy and Safety Analyses Evaluating Mirvetuximab Soravtansine in Ovarian Cancer at ASCO https://t.co/5KIObOvMHV #cancer
0
0
0
$IMGN ~Hey guys don't miss the next Move in a few hours. https://t.co/oX414N6JBA
0
0
0
Dreamer! Are your $IMGN tokens ready to be burned for a @communi3_io NFT? 🔥🔥 30$IMGN tickets for one entry ☁️ Follow @DahlysArt and @DahlyDream, like and RT this tweet and get a chance to win 10 raffle entries. 🤝 Winner in 72 hours Raffle link: https://t.co/1Y1U1O4P8g https://t.co/pa4yf7ndDU
10
29
37
#ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences $IMGN https://t.co/n3u7u4EQ3U
0
0
0
Big and Fluffy 😳😳 Dahlys Gen2, Imaginary Friends and Nightmarish Creatures, soon. Are your shrooms 🍄and $IMGN ready? Follow @DahlysArt and @DahlyDream then like and RT this tweet for a chance to win a free Dahly Gen2! Winner in 48 Hours. #NFTs #SolanaNFTs #Solana #Bookish https://t.co/3XFJ1EZEgG
35
113
141
$IMGN - ImmunoGen (IMGN) Investor Presentation - Slideshow. https://t.co/MEn7NppFf6 #investing #business #stockmarket
0
0
0
$IMGN, $IMGN What's Going On With ImmunoGen Shares Today? - https://t.co/IyY7cPt90Z
0
0
0
Increasing unusual call volume: $RENT $IMGN $MNKD $VMW $CHPT $NTNX $MLCO Increasing unusual put volume: $MSOS $ROST $VMW $ANF $DFS $CDEV $BBY
3
2
27
I've always been a fan the art of @DahlysArt. I heard so many positive statements about team, future plans and $IMGN so I couldn't resist. I was feeling very #Bookish and got this one! Embrace me Dahlys family! https://t.co/g2294pQCov
14
13
44
$IMGN ImmunoGen's stock is up 12% after the FDA accepts application for new ovarian-cancer therapy https://t.co/LtZpt30YF4
0
0
0
$IMGN application filed and accepted BLA for mirvetuximab soravtansine monotherapy in patients with folate receptor alpha (FRα)-high platinum-resistant ovarian cancer for priority review. PDUFA 11/28/22. Will be watching. (Sitting around 3.80 PM, low vol) https://t.co/ItwLTqyuwB https://t.co/EODtt5nZrs
2
0
6
$IMGN ImmunoGen Announces Acceptance Of Biologics License Application For Mirvetuximab Soravtansine In Ovarian Cancer By US Food And Drug Administration With Priority Review #cancer Stock News Alerts In Bio
0
1
1
$IMGN [15s. delayed] filed form SC 13G on May 19, 16:50:53 https://t.co/aTkfIcb9tA
0
0
0
Dreamers, here’s a new Sneak Peek from our Gen 2 Collection. 👀 You’ll need 3 Shrooms + 600 $IMGN to mint this beauty. 🍄 Gamified Staking Link: https://t.co/Znz6OQ8bjv 📖 Any interaction with this tweet can get you a free Dahlys Gen 2 😉 https://t.co/3QdVuhBmnD
42
91
131